AAO 2018 Speakers

Ellie Chabi

Ellie Chabi, MD

By Jackie Wengrod | October 24, 2018

Ellie Chabi, MD is the Therapeutic Area Head for Glaucoma & Neuroprotection as well as the Lead for Artificial Intelligence Programs within Global Biomedical Science…

Read More
Mitul Mehta

Mitul Mehta, MD

By Jackie Wengrod | October 24, 2018

Mitul is a cofounder of Eyedaptic and a board-certified ophthalmologist with fellowship training in medical and surgical diseases of the retina at UCI’s Gavin Herbert…

Read More
Adam Rogers

Adam Rogers

By Jackie Wengrod | October 24, 2018

Adam Rogers is the CEO and Co-Founder of Hemera Biosciences, a clinical stage company treating retinal diseases with gene therapy.

Read More
Charles Semba

Charles Semba, MD

By Jackie Wengrod | October 17, 2018

Charles has 17 years of clinical drug development experience in retina, ocular surface disease, and glaucoma. He held senior leadership positions at Genentech, Shire, SARcode…

Read More
Patrik DeHaes

Patrik De Haes, MD

By Jackie Wengrod | October 16, 2018

Patrik De Haes, MD, has over 25 years of experience in the global healthcare industry in product development, marketing and general management. Before joining Oxurion…

Read More
Dale Wiggins

Dale Wiggins

By Jackie Wengrod | October 16, 2018

Dale Wiggins is Vice President and General Manager of the Philips HealthSuite Digital Platform. The HealthSuite Digital Platform (HSDP) is the center for first time…

Read More
Andrew Stewart

Andrew Stewart

By Jackie Wengrod | October 16, 2018

Andrew is responsible for the US Commercial Retina Business at Allergan and is located in Irvine, CA. Prior to joining the Commercial Team, Andrew was…

Read More
Ramin Valian

Ramin Valian

By Jackie Wengrod | October 16, 2018

Ramin Valian has over two decades of sales leadership, marketing and strategic planning experience in the specialty pharmaceutical and biotech business, and over 13 years’…

Read More
Andrew Levien

Andrew Levien

By Jackie Wengrod | October 15, 2018

Andrew Levien is Chief Executive Officer and director of ArcScan and has been with the company since 2009 and as CEO since 2012. Over the…

Read More
David Eveleth

David Eveleth

By Jackie Wengrod | October 15, 2018

David Eveleth is currently CEO of Trefoil Therapeutics. Previously he was a consultant to several biotechnology companies and venture capital groups. Prior to this, David…

Read More
Brian Lawrence

Brian Lawrence, PhD

By Jackie Wengrod | October 15, 2018

Dr. Lawrence is a co-founder of the company and co-inventor of the company’s SDP technology. He has over 12 years’ experience in developing silk-based biomaterials…

Read More
Olav Hellebo

Olav Hellebø

By Jackie Wengrod | October 15, 2018

Olav Hellebø joined ReNeroun group in the UK as CEO in 2014. Previously he was CEO of the oncology biotech Clavis Pharma in Oslo, Norway.…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.